No connection

Search Results

ASRT vs SRTS

ASRT
Assertio Holdings, Inc.
BEARISH
Price
$11.66
Market Cap
$74.8M
Sector
Healthcare
AI Confidence
85%
SRTS
Sensus Healthcare, Inc.
BEARISH
Price
$4.49
Market Cap
$73.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ASRT
--
SRTS
--
Forward P/E
ASRT
7.77
SRTS
70.9
P/B Ratio
ASRT
0.71
SRTS
1.54
P/S Ratio
ASRT
0.54
SRTS
2.69
EV/EBITDA
ASRT
1.98
SRTS
-5.27

Profitability

Gross Margin
ASRT
65.47%
SRTS
43.18%
Operating Margin
ASRT
28.72%
SRTS
-63.74%
Profit Margin
ASRT
-21.06%
SRTS
-28.09%
ROE
ASRT
-24.48%
SRTS
-14.85%
ROA
ASRT
-4.17%
SRTS
-11.18%

Growth

Revenue Growth
ASRT
69.4%
SRTS
-62.2%
Earnings Growth
ASRT
--
SRTS
--

Financial Health

Debt/Equity
ASRT
0.38
SRTS
0.01
Current Ratio
ASRT
1.58
SRTS
9.72
Quick Ratio
ASRT
1.41
SRTS
5.96

Dividends

Dividend Yield
ASRT
--
SRTS
--
Payout Ratio
ASRT
0.0%
SRTS
0.0%

AI Verdict

ASRT BEARISH

ASRT's Piotroski F-Score of 2/9 indicates severe financial distress, with weak profitability, negative ROE and ROA, and inconsistent earnings performance. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given negative earnings and high revenue volatility. Despite strong revenue growth (69.4% YoY) and a low price-to-sales ratio (0.54), the company trades at a significant discount due to deep operational losses and poor capital efficiency. Insider selling activity and a 5-year price decline of 80.4% further undermine confidence. The stock's current valuation appears unsustainable without a clear path to sustained profitability.

Strengths
69.4% YoY revenue growth indicates strong top-line momentum
High gross margin of 65.47% suggests strong pricing power or cost control
Low price-to-sales ratio (0.54) implies potential undervaluation on a revenue basis
Risks
Piotroski F-Score of 2/9 signals extreme financial weakness and distress
Negative ROE (-24.48%) and ROA (-4.17%) indicate poor return on capital
Persistent net losses (profit margin -21.06%) and inconsistent earnings surprises
SRTS BEARISH

SRTS exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY revenue decline of 62.20%. While the company maintains a strong liquidity position with a Current Ratio of 9.72 and negligible debt, these are offset by negative operating margins (-63.74%) and a consistent failure to meet earnings estimates. The recent short-term price appreciation contradicts the underlying financial decay and the bearish technical trend score of 0/100. Overall, the company is in a state of operational distress despite its clean balance sheet.

Strengths
Extremely low leverage (Debt/Equity: 0.01)
High short-term liquidity (Current Ratio: 9.72)
Positive Gross Margin (43.18%)
Risks
Severe revenue collapse (-62.20% YoY)
Deeply negative operating margins (-63.74%)
Poor earnings quality (Piotroski F-Score: 2/9)

Compare Another Pair

ASRT vs SRTS: Head-to-Head Comparison

This page compares Assertio Holdings, Inc. (ASRT) and Sensus Healthcare, Inc. (SRTS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile